Not recruiting
Polycythaemia vera+3
Not recruitingStudy of Gandotinib for Patients with Myeloproliferative Neoplasms, Myelofibrosis, Essential Thrombocythemia, or Polycythemia Vera
InvestigationalNo placebo
Study of Gandotinib for Patients with Myeloproliferative Neoplasms, Myelofibrosis, Essential Thrombocythemia, or Polycythemia Vera
InvestigationalNo placebo
- Disease:Polycythaemia veraEssential thrombocythaemia+2
- Substances:Gandotinib
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Gandotinib


